WINTER SPRINGS, Fla., April 05, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market opens on Friday, April 29th. IRADIMED management will host a conference call the same...
IRADIMED Announces Special $1.00 Per Share Cash Dividend
WINTER SPRINGS, Fla., Feb. 07, 2022 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), announced that its Board of Directors approved a special cash dividend of $1.00 per share on the Company's outstanding common stock. This special cash dividend is payable on...
IRADIMED CORPORATION Announces Fourth Quarter 2021 Financial Results
Reports fourth quarter 2021 revenue of $11.9 million, GAAP diluted EPS of $0.31 and non-GAAP diluted EPS of $0.33Announces full-year and first quarter 2022 financial guidance WINTER SPRINGS, Fla., Feb. 04, 2022 -- iRadimed Corporation (the "Company") (NASDAQ: IRMD), a...
IRADIMED CORPORATION to Hold 2021 Fourth Quarter Financial Results Conference Call on February 4th
WINTER SPRINGS, Fla., Jan. 20, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market opens on Friday, February 4th. IRADIMED management will host a conference call the same...
IRADIMED CORPORATION Announces Third Quarter 2021 Financial Results
Reports third quarter 2021 revenue of $10.9 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Increases full-year 2021 financial guidance WINTER SPRINGS, Fla., Oct. 29, 2021 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leader in the...
IRADIMED CORPORATION to Hold 2021 Third Quarter Financial Results Conference Call on October 29th
WINTER SPRINGS, Fla., Oct. 08, 2021 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 third quarter financial results before the market opens on Friday, October 29th. IRADIMED management will host a conference call the same...
IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results
Reports second quarter 2021 revenue of $9.8 million, GAAP diluted EPS of $0.12 and non-GAAP diluted EPS of $0.14Issues Q3 and full year 2021 financial guidance WINTER SPRINGS, Fla., July 30, 2021 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leader in the...
IRADIMED CORPORATION to Hold 2021 Second Quarter Financial Results Conference Call on July 30th
WINTER SPRINGS, Fla., July 07, 2021 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 second quarter financial results before the market opens on Friday, July 30th. IRADIMED management will host a conference call the same...
IRADIMED CORPORATION Announces First Quarter 2021 Financial Results
Reports first quarter 2021 revenue of $9.2 million, GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.13Reports combined cash and investments of $52.7 million as of March 31, 2021 WINTER SPRINGS, Fla., April 30, 2021 -- IRADIMED CORPORATION (the "Company")...
IRADIMED CORPORATION to Hold 2021 First Quarter Financial Results Conference Call on April 30th
WINTER SPRINGS, Fla., April 09, 2021 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 first quarter financial results before the market opens on Friday, April 30th. IRADIMED management will host a conference call the same...